Skip to main content

Advertisement

SpringerLink
Log in

Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy

  • Original Article
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

Previous studies have identified a diverse set of predisposing factors for the occurrence of hemorrhagic transformation (HT), but the independent clinical predictors of HT after intraarterial thrombolysis have not been determined. In this retrospective study, we investigated the characteristics of patients with or without HT who had received intra-arterial thrombolysis therapy, using biochemical analysis, renal function test, routine blood test, blood lipid test, coagulation blood test, liver function test, random blood glucose test, timewindow for intra-arterial thrombolysis, recanalization, National Institutes of Health Stroke Scale (NIHSS) score and systolic blood pressure before intra-arterial thrombolysis. The mortality rates were similar in the HT and non-HT groups (P = 0.944). In the singlefactor analysis, patients with a higher globulin level (P <0.002), prothrombin time activity percentage (PTA; P = 0.026), and NIHSS score (P = 0.002), had a significantly increased risk of developing HT. In the multifactor logistic regression model involving globulin level, PTA, white blood cell count, and NIHSS score, the globulin level (P <0.001; OR, 1.185; 95% confidence interval [CI], 1.090–1.288), PTA (P = 0.018; OR, 1.016; 95% CI, 1.003–1.029), white blood cell count (P = 0.025; OR, 1.097; 95% CI, 1.012–1.190) and NIHSS score (P = 0.003; OR, 1.097; 95% CI, 1.031–1.166) were significantly increased in the HT group. The increase in globulin level is an independent risk factor for HT in patients receiving intra-arterial thrombolysis. The possible mechanisms may involve inflammatory cytokines, matrix metalloproteinase 9, and positive acute-phase reactants synthesized by the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke 1999, 30: 1326–1332.

    Article  CAS  PubMed  Google Scholar 

  2. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke 2011, 42: 2235–2239.

    Article  PubMed  Google Scholar 

  3. Kidwell CS, Saver JL, Carneado J, Sayre J, Starkman S, Duckwiler G, et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002, 33: 717–724.

    Article  PubMed  Google Scholar 

  4. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke 1997, 28: 2109–2118.

    Article  Google Scholar 

  5. Molina CA, Alvarez-Sabin J, Montaner J, Abilleira S, Arenillas JF, Coscojuela P, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002, 33: 1551–1556.

    Article  PubMed  Google Scholar 

  6. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007, 24: 1–10.

    Article  PubMed  Google Scholar 

  7. D’Amelio M, Terruso V, Famoso G, Ragonese P, Aridon P, Savettieri G. Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke. Cerebrovasc Dis 2011, 32: 234–238.

    Article  PubMed  Google Scholar 

  8. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274: 1017–1025.

    Article  CAS  PubMed  Google Scholar 

  9. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352: 1245–1251.

    Article  CAS  PubMed  Google Scholar 

  10. Um J Y, Jeong HJ, Park RK, Hong SH, Kim HM. Aspects of gene polymorphisms in cerebral infarction: inflammatory cytokines. Cell Mol Life Sci 2005, 62: 824–833.

    Article  CAS  PubMed  Google Scholar 

  11. Ji J, Liu HL, Cheng JL. Effects of “three ways” method of acupuncture on serum levels of tumor necrosis factoralpha and interleukin-1beta patients with acute ischemic cerebrovascular diseases. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006, 26: 500–503.

    CAS  PubMed  Google Scholar 

  12. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994, 122: 135–139.

    Article  CAS  PubMed  Google Scholar 

  13. Jickling GC, Ander BP, Stamova B, Zhan X, Liu D, Bsc LR, et al. RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol 2013. Doi: 10.1002/ana.23883.

    Google Scholar 

  14. Woods A, Brull DJ, Humphries SE, Montgomery HE. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 2000, 21: 1574–1583.

    Article  CAS  PubMed  Google Scholar 

  15. Beamer N, Coull BM, Sexton G, de Garmo P, Knox R, Seaman G. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke 1993, 24: 1133–1139.

    Article  CAS  PubMed  Google Scholar 

  16. Marinkovic S, Jahreis GP, Wong GG, Baumann H. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 1989, 142: 808–812.

    CAS  PubMed  Google Scholar 

  17. Lyoumi S, Tamion F, Petit J, Dechelotte P, Dauguet C, Scotte M, et al. Induction and modulation of acute-phase response by protein malnutrition in rats: comparative effect of systemic and localized inflammation on interleukin-6 and acute-phase protein synthesis. J Nutr 1998, 128: 166–174.

    CAS  PubMed  Google Scholar 

  18. Dayer JM, Choy E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology 2010, 49: 15–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Huwiler A, Akoolel S, Aschrafi A, Hamada FM, Pfeilschifter J, Eberhardt W. ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR. J Biol Chem 2003, 278: 51758–51769.

    Article  CAS  PubMed  Google Scholar 

  20. Lee HS, Miau LH, Chen CH, Chiou LL, Huang GT, Yang PM, et al. Differential role of p38 in IL-1alpha induction of MMP-9 and MMP-13 in an established liver myofibroblast cell line. J Biomed Sci 2003, 10: 757–765.

    CAS  PubMed  Google Scholar 

  21. Reihmane D, Jurka A, Tretjakovs P. The relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrations. Scand J Immunol 2012, 76: 188–192.

    Article  CAS  PubMed  Google Scholar 

  22. Li X, Wang R, Wang X, Xue X, Ran D, Wang S. Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage. Mol Med Rep 2013, 7: 1261–1266.

    CAS  PubMed  Google Scholar 

  23. Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003, 34: 40–46.

    Article  CAS  PubMed  Google Scholar 

  24. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002, 33: 831–836.

    Article  CAS  PubMed  Google Scholar 

  25. Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 2009, 28: 119–123.

    Article  CAS  PubMed  Google Scholar 

  26. Kimura K, Iguchi Y, Shibazaki K, Aoki J, Terasawa Y. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery. J Neurol Sci 2008, 272: 136–142.

    Article  CAS  PubMed  Google Scholar 

  27. Adams HP, Jr., Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34: 1056–1083.

    Article  PubMed  Google Scholar 

  28. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38: 1655–1711.

    Article  PubMed  Google Scholar 

  29. Hallevi H, Barreto AD, Liebeskind DS, Morales MM, Martin-Schild SB, Abraham AT, et al. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2009, 40: 1780–1785.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, the First Norman Bethune Hospital of Jilin University, Changchun, 130021, China

    Yingqi Xing, Zhen-Ni Guo, Shuo Yan, Hang Jin, Shouchun Wang & Yi Yang

Authors
  1. Yingqi Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhen-Ni Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuo Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hang Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shouchun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Yang.

Additional information

These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xing, Y., Guo, ZN., Yan, S. et al. Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy. Neurosci. Bull. 30, 469–476 (2014). https://doi.org/10.1007/s12264-013-1440-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-013-1440-x

Keywords

Search

Navigation